Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatmentShiyun Cui, Xiaofeng Chen, Qiuyu Wu et al.|npj Precision Oncology|2025Cited by 4